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ABSTRACT The replication cycle of human cytomegalovirus (CMV) leads to drastic
reorganization of domains in the host cell nucleus. However, the mechanisms in-
volved and how these domains contribute to infection are not well understood. Our
recent studies defining the CMV-induced nuclear proteome identified several viral
proteins of unknown functions, including a protein encoded by the UL31 gene. We
set out to define the role of UL31 in CMV replication. UL31 is predicted to encode a
74-kDa protein, referred to as pUL31, containing a bipartite nuclear localization signal,
an intrinsically disordered region overlapping arginine-rich motifs, and a C-terminal
dUTPase-like structure. We observed that pUL31 is expressed with true late kinetics
and is localized to nucleolin-containing nuclear domains. However, pUL31 is ex-
cluded from the viral nuclear replication center. Nucleolin is a marker of nucleoli,
which are membrane-less regions involved in regulating ribosome biosynthesis and
cellular stress responses. Other CMV proteins associate with nucleoli, and we demon-
strate that pUL31 specifically interacts with the viral protein, pUL76. Coexpression of
both proteins altered pUL31 localization and nucleolar organization. During infec-
tion, pUL31 colocalizes with nucleolin but not the transcriptional activator, UBF. In
the absence of pUL31, CMV fails to reorganize nucleolin and UBF and exhibits a rep-
lication defect at a low multiplicity of infection. Finally, we observed that pUL31 is
necessary and sufficient to reduce pre-rRNA levels, and this was dependent on the
dUTPase-like motif in pUL31. Our studies demonstrate that CMV pUL31 functions in
regulating nucleolar biology and contributes to the reorganization of nucleoli during
infection.
IMPORTANCE Nucleolar biology is important during CMV infection with the nucleo-
lar protein, with nucleolin playing a role in maintaining the architecture of the viral
nuclear replication center. However, the extent of CMV-mediated regulation of nu-
cleolar biology is not well established. Proteins within nucleoli regulate ribosome
biosynthesis and p53-dependent cellular stress responses that are capable of induc-
ing cell cycle arrest and/or apoptosis, and they are proposed targets for cancer ther-
apies. This study establishes that CMV protein pUL31 is necessary and sufficient to
regulate nucleolar biology involving the reorganization of nucleolar proteins. Under-
standing these processes will help define approaches to stimulate cellular intrinsic
stress responses that are capable of inhibiting CMV infection.
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Human cytomegalovirus (CMV) is a member of the betaherpesvirus family, whichalso includes human herpesviruses 6A, 6B, and 7 (reviewed in reference 1). While
often asymptomatic in healthy adults, CMV infection can cause severe disease in
immunocompromised patients and is a leading infectious cause of birth defects.
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Anti-CMV pharmaceuticals, such as ganciclovir (GCV), have significantly improved the
management of CMV-associated diseases. However, the use of these medications is
limited due to toxicity and the emergence of drug-resistant strains (2). Human CMV
consists of an approximately 235-kbp double-stranded DNA genome that is contained
within an icosadeltahedral nucleocapsid and surrounded by an envelope. The genome
encodes approximately 200 open reading frames (ORFs), with the potential to express
over 750 viral proteins that are separated into different kinetic classes of expression (1,
3–8). The functions of many of these proteins remain unknown.
The viral replication cycle of CMV leads to drastic reorganization of the nucleus in
infected cells (reviewed in reference 9). This is evident based on the profound enlarge-
ment of the nucleus, which doubles in size by 72 h postinfection (hpi), and its
deformation late during infection (10, 11). The changes are partially the result of an
accumulation of nuclear viral proteins exhibiting a wide range of activities. Our recent
studies defining changes in the nuclear proteome identified 36 viral proteins associated
with the nucleus by 24 hpi (10), and this includes proteins involved in genome replication
(e.g., pUL54 DNA polymerase, pUL44 processivity factor, and pUL102 helicase-primase
subunit), nucleotide metabolism (e.g., pUL45 RNase reductase, pUL114 uracil-DNA glyco-
sylase, and pUL98 DNase), transcriptional regulation (e.g., TIP60 regulator pUL27, NuRD
complex regulator pUL29, and STAT3 regulator pUL123), and capsid assembly (pUL46
capsid triplex subunit, pUL80 capsid maturation protease, and pUL86 major capsid
protein) (1, 12–18). Several viral proteins were identified which lack known functions
(e.g., US23, US24, UL25, and UL31) (10). In addition to altered protein content, infection
also changes host cell nuclear architecture. The nucleus contains diverse membrane-
less subdomains that compartmentalize cellular processes. Many of the changes are
associated with the formation of a viral nuclear replication compartment. This process
results in partitioning of the host genome (19, 20) and rearranging a large subset of
cellular proteins (9). For instance, components of the cellular proteasome and the
nucleolar marker, nucleolin, are relocalized to the periphery of the nuclear replication
compartment (21, 22). Nucleolin is required for targeting pUL84 and the viral proces-
sivity factor, pUL44, to this compartment for efficient viral genome synthesis (23, 24).
The nuclear architecture is also impacted by the creation of subnuclear domains that
impede viral replication. These structures include promyelocytic leukemia protein
nuclear bodies (PML-NBs). After entry into the nucleus, most CMV genomes localize
with PML-NBs, which repress viral transcription (reviewed in reference 25). However,
CMV proteins IE1 and pp71 disrupt PML-NBs, promoting viral replication. These exam-
ples support the conclusion that CMV-mediated rearrangement of functional nuclear
domains is crucial for viral replication.
Prominent subdomains in the nucleus are nucleoli (reviewed in reference 26).
Nucleoli are membrane-less regions of concentrated ribosomal DNA (rDNA) that func-
tion in ribosome biogenesis. In uninfected cells, nucleoli are made up of three sub-
nucleolar compartments, known as the fibrillar center (FC), dense fibrillar component
(DFC), and granular component (GC), with each functioning in a distinct phase of
ribosome biogenesis. Transcription of rDNA into pre-rRNA occurs at the border of FC
and DFC. The FC contains RNA polymerase I and transcription factors, such as UBF
(upstream binding factor), while the multifunctional protein, nucleolin, is observed in
both FC and DFC regions. The early processing steps of pre-rRNA occur in the DFC, and
the final stages of ribosome rRNA-protein assembly occur in the GC. The structure of
nucleoli is characterized by fluid organization that is maintained by multivalent protein-
protein and protein-nucleic acid interactions (27, 28). Proteins with intrinsically disor-
dered regions (IDRs) often mediate these interactions. For example, purified nucleolar
proteins fibrillarin and nucleophosmin, both of which contain IDRs, can phase separate
into distinct subnucleolar-like domains in vitro (27). Nucleoli also play essential roles in
sensing and responding to cellular stresses. Stresses, such as viral infection and DNA
damage, lead to changes in the organization and protein composition of nucleoli. This
results in stress-induced activation of p53-dependent and -independent signaling
pathways due to changes in nucleolar protein-protein interactions (26). Recently,
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chemical induction of this pathway was shown to be antiviral against both mouse and
human CMV (29). However, the impact of CMV infection on nucleolar biology remains
unclear.
In previous studies, we detected multiple peptides matching to the predicted ORF
of UL31 (10). UL31 is in all published genomes of CMV, contains a conserved dUTPase-
like motif, and is detected in ribosomal profile studies as CMV ORFL87W (3, 30). We set
out determine the contribution of the protein pUL31 to CMV replication. We observed
that pUL31 is expressed with true late kinetics and accumulates in nucleolar-like
domains at late times during infection. Further, we demonstrate that pUL31 is both
necessary and sufficient to regulate pre-rRNA levels and nucleolar organization, con-
tributing to efficient CMV replication.
RESULTS
Characterization of CMV pUL31 protein expression. CMV expresses a diverse
repertoire of proteins involved in regulating cellular processes, with many of these
processes occurring within the nucleus. Our previous studies defined CMV-mediated
changes in the nuclear proteome and uncovered several viral nuclear proteins of
unknown functions (10). This included three peptides that matched to a protein
expressed from the predicted UL31 ORF. CMV UL31 is positioned antisense to the
neighboring UL30 (early expression kinetics) and UL32 (true late expression kinetics)
genes (Fig. 1A) (7, 8). Recent studies demonstrated that mRNAs containing UL32 use a
polyadenylation signal between UL30 and UL31 with small noncoding RNAs expressed
from UL31 (31). The UL31 gene is conserved in published genomes of CMV, including
clinical and laboratory-adapted strains (4). Further, ribosomal profiling studies by
Stern-Ginossar et al. (3) defined the UL31 ORF (ORFL87W) in the CMV Merlin strain
starting at an ATG upstream of most annotated genomes. CMV UL31 codes for a
671-amino-acid protein, pUL31, with a predicted molecular mass of 74 kDa.
To begin investigating pUL31, we evaluated the primary amino acid sequence with
the results summarized in Table 1 and Fig. 1A. CMV pUL31 contains a predicted
amino-terminal bipartite nuclear localization signal (NLS), (K/R)(K/R)x10–12(K/R)3/5,
where x represents any amino acid (32). This type of NLS uses the classical nuclear
import machinery, importin- and - (reviewed in reference 40), and exists in the
nucleolar protein, nucleolin. At the carboxyl terminus, the protein contains a motif
conserved in the U10 proteins of beta-herpesviruses HHV6A, -6B, and -7 (DUF570;
domain of unknown function), which exhibit structural features similar to those of
monomeric dUTPases (30, 36). dUTPases are nucleotidohydrolases that hydrolyze dUTP
to dUMP, and several CMV proteins have dUTPase-like features, including pUL72, pp71,
pp65, and pUL84, yet do not exhibit dUTPase activity (30). Finally, the amino terminus
of pUL31 is predicted to be an intrinsically disordered region (IDR) and contains several
arginine-rich motifs (R-motifs, for RxnR, where x is any amino acid at an n value of 2)
(41). These features have been observed in cellular proteins associated with nucleoli
and are proposed to participate in the liquid-like phase separation that defines nucle-
olar compartments (27).
To examine CMV pUL31 during infection, we constructed a recombinant virus
containing the YFP (yellow fluorescence protein) gene in frame with UL31 at the
carboxy terminus in an AD169 background, and we refer to this bacterial artificial
chromosome (BAC)-derived virus as the UL31YFP virus (Fig. 1A). Because the neighbor-
ing genes are important for CMV replication (42), we evaluated the replication kinetics
of UL31YFP virus compared to those of the BAC-derived AD169 virus (ADWT). We
infected MRC-5 fibroblasts at a multiplicity of infection (MOI) of 3 or 0.05 infectious
units per cell (IU/cell) and quantified changes in viral DNA levels normalized to the
cellular gene encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH). We ob-
served similar increases in viral genomes between the two viruses as well as similar viral
titers (Fig. 1B and C). These data demonstrate that introduction of the YFP tag does not
disrupt CMV replication and likely preserves wild-type levels of UL30 and UL32 gene
expression. To begin evaluating UL31, we quantified UL31 RNA levels during infection
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using the UL31YFP virus along with AD169 encoding green fluorescent protein (ADGFP)
and BAC-derived TB40/E (TBGFP) viruses. We infected fibroblasts as described above and
isolated total RNA from infected cells at multiple time points. Because the UL32 mRNA
contains the antisense UL31 sequence, we used gene-specific primers for UL31 as well
as GAPDH to synthesize cDNA (Fig. 1A). We observed increasing levels of UL31 RNA
FIG 1 Expression of CMV pUL31 during infection. (A) The UL30 and UL32 ORFs are positioned antisense to the UL31 ORF, with
the UL32 mRNA using a polyadenylation signal (pA) between UL30 and UL31. A recombinant virus, UL31YFP, contains the
yellow fluorescent protein (YFP) gene in frame with the UL31 ORF at the 3= end in the CMV AD169 background. Solid arrows
indicate locations of primers for gene-specific (primer; open arrow) quantitative RT-PCR analysis. The UL31 ORF is predicted
to express a 671-amino-acid protein with an N-terminal bipartite nuclear localization signal (NLS), multiple arginine-rich
R-motifs (RxnR; where x is any amino acid and n is 2) overlapping an intrinsic disordered region (IDR), and a domain of
unknown function (DUF570) in beta-herpesviruses containing a dUTPase-like motif. (B) Fibroblasts were infected with ADWT or
UL31YFP virus at an MOI of 3. Relative viral DNA levels were determined at the indicated times using quantitative PCR and
primers against UL123 and GAPDH. Viral titers at 72 hpi were determined using a TCID50 assay following infections using ADWT
or UL31YFP virus. Data are from three biological and two technical replicates, with error bars representing standard deviations
from the means. (C) Viral DNA levels were determined as described for panel B using an MOI of 0.05. (D) MRC-5 fibroblasts were
infected with AD169 (ADGFP), TB40/E (TBGFP), or UL31YFP virus at an MOI of 3.0. Total RNA was isolated at the indicated times,
and UL31 and GAPDH levels were determined by quantitative RT-PCR using gene-specific primers. Data are from three
biological and two technical replicates, with error bars representing standard deviations from the means. To calculate statistical
significance, an ANOVA was used to compare the three conditions. An asterisk indicates a significant P value of less than 0.05.
(E) Fibroblasts were mock infected (m) or infected with UL31YFP virus at an MOI of 3. Whole-cell lysates were collected at
multiple times postinfection and analyzed by Western blotting using antibodies against the indicated proteins. As a control,
ADGFP was analyzed at 72 hpi.
TABLE 1 Distinct features identified in the CMV pUL31 primary amino acid sequence
Motif Amino acids Predicted function Search algorithm Reference(s)
Bipartite NLSa 2–24 Classical nuclear import pathway cNLS Mapper 32, 33
IDR 1–182 Conformational flexibility, phase
separation with R-motif
DisEMBL, IUPred 27, 34–35, 79
R-motifb 26–33, 44–47, 148–152,
181–186, 219–222,
518–521, 608–610
Nucleolar localization, phase
separation with IDR
27, 41
DUF570 206–626 Conserved in HHV-6A, -6B,
and -7 U10
Conserved Domain Database 36
Monomeric dUTPase-like fold 521–669 Nucleotide metabolism, PAMPc Robetta, Phyre2 30, 37, 38, 39
a(K/R)(K/R)X10–12(K/R)3/5 where X is any amino acid.
b(RXn1R) where X is any amino acid and n1 is 2.
cPAMP, pathogen-associated molecular patterns.
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after 24 hpi, with slightly higher levels detected during TB40GFP infection compared to
both ADGFP and UL31YFP infection (Fig. 1D). Finally, the UL31 gene is predicted to
express a 74-kDa protein. We tested for pUL31 protein expression following infection
of fibroblasts using the UL31YFP virus and Western blot (WB) analysis using an antibody
against GFP cross-reacting with YFP. We detected a single band at approximately 100
kDa in size starting at 48 hpi, with increasing steady-state levels out to 96 hpi (Fig. 1E).
This signal is consistent with pUL31 (74 kDa) containing the YFP tag (26 kDa) and
follows the kinetics of UL31 RNA expression (Fig. 1D). As a control, we infected
fibroblasts with a recombinant strain, ADGFP, expressing free GFP, which shows an
approximately 26-kDa protein that is not seen upon UL31YFP infection (Fig. 1E). Our
data demonstrate that the CMV UL31 gene, corresponding to ORFL87W (3), encodes an
approximately 74-kDa protein at late times during infection.
CMV pUL31 is a nucleolar protein expressed with true late kinetics. To deter-
mine pUL31 protein expression kinetics, fibroblasts were mock infected or infected with
the UL31YFP virus, and cell lysates were collected between 6 and 96 hpi. We analyzed
expression of three kinetic classes of CMV proteins using Western blotting. This
included CMV IE1, pUL44, and pp28, representing proteins with immediate-early,
early-late, and true late kinetics, respectively (Fig. 2A). Expression of pUL31 again was
detected starting at 48 hpi and increased out to 96 hpi. Under these conditions, pUL31
expression kinetics were similar to those of the true late gene pp28 (Fig. 2A) (8).
Expression of true late viral genes is dependent upon viral DNA synthesis. To determine
whether pUL31 is a true late viral gene, fibroblasts were infected with UL31YFP virus in
the presence or absence of ganciclovir (GCV), an inhibitor of the viral DNA polymerase
(Fig. 2B). CMV IE1, whose expression is not dependent upon viral DNA synthesis, was
minimally affected by GCV treatment (Fig. 2B). pUL31 protein expression at both 48 and
72 hpi and UL31 RNA expression at 96 hpi were inhibited by GCV, similar to what we
observed for pp28 (Fig. 2B). These data demonstrate that pUL31 is expressed as a true
late viral gene.
FIG 2 CMV pUL31 is expressed as a true late gene product. (A) MRC-5 fibroblasts were infected with the
UL31YFP virus at an MOI of 3. Whole-cell lysates were collected at multiple times postinfection and analyzed
by Western blotting using antibodies against the indicated proteins. (B) Fibroblasts were infected using the
UL31YFP virus at an MOI of 3 and treated with 10 M ganciclovir (GCV) or vehicle control for the duration
of the infection. Total RNA was isolated at the indicated times, and UL31 and GAPDH levels were
determined by quantitative RT-PCR using gene-specific primers. Whole-cell lysates were collected at the
indicated times and analyzed using Western blotting. (C) At 24, 48, and 72 hpi, UL31YFP-infected fibroblasts
were fixed, permeabilized, and stained using DAPI and an antibody against CMV IE1.
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To investigate the subcellular localization of pUL31 during infection, fibroblasts were
infected with the UL31YFP virus and fixed at 24, 48, and 72 hpi for analysis using
immunofluorescence (IF) and confocal microscopy. Cells were stained for CMV IE1 as a
control for infected cells (Fig. 2C). At 48 hpi, pUL31 expression, defined by YFP
fluorescence, was localized juxtanuclear and throughout the nucleus of infected cells
(Fig. 2C). By 72 hpi, pUL31 was visible in the nucleus and seemed to accumulate inside
distinct subnuclear compartments (Fig. 2C). The juxtanuclear staining was not visible at
72 hpi (Fig. 2C). Areas of the nucleus that exhibit a reduced 4=,6-diamidino-2-
phenylindole (DAPI) staining include nucleoli. To evaluate if pUL31 localized to nucleoli,
we transfected U373 cells with the nucleolar protein nucleolin fused with the mCherry
fluorescence tag. We infected nucleolin-mCherry-expressing cells with either ADGFP or
UL31YFP virus and evaluated localization using live-cell imaging (Fig. 3). At 48 and 72
hpi for both infections, we observed nucleolin-mCherry fluorescence within subnucleo-
lar domains, consistent with the known localization of nucleolin to nucleoli (Fig. 3A and
B). Because CMV reorganizes cellular processes and intracellular domains, it remains to
be determined whether nucleoli seen in CMV-infected cells represent nucleoli as
defined in uninfected cells. Therefore, we have referred to the area as nucleolar-like
domains. ADGFP-infected cells, which express free GFP, exhibited diffuse GFP fluores-
cence with reduced levels colocalizing with nucleoli-mCherry (Fig. 3A). In contrast,
pUL31 colocalized with nucleolin-mCherry (Fig. 3B). Our studies demonstrate that the
localization of pUL31 within infected cells is dynamic, being juxtanuclear initially upon
expression, accumulating in the nucleus, and ending within nucleolin-containing do-
mains at late times.
To more precisely define localization, we fixed and stained infected fibroblasts at 72
hpi using antibodies to CMV pUL44 and major capsid protein (MCP) as well as nucleolar
markers, nucleolin, and the Pol I transcription factor, UBF (upstream binding factor).
Both pUL44 and MCP are known to localize to the viral nuclear replication compart-
ment during infection. Using confocal microscopy, we observed pUL44 and MCP within
replication compartments (Fig. 4). In contrast, the majority of signal for pUL31 was
excluded from this compartment and was concentrated in domains consistent with
FIG 3 pUL31-YFP localizes with the nucleolar marker nucleolin-mCherry in live cells during infection.
U373 cells were transfected with a plasmid expressing nucleolin fused to the mCherry fluorescent
protein. At 24 h posttransfection, cells were infected with either ADGFP (A) or UL31YFP (B) virus at an MOI
of 3 and analyzed at 48 and 72 hpi using live cell imaging.
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nucleolar localization (Fig. 4). We observed that pUL31 localized within domains
containing both nucleolin and UBF. Nucleolin is a nucleolar marker that accumulates in
both fibrillar center (FC) and dense fibrillar compartment (DFC), while UBF accumulates
in the FC (26). We evaluated the localization of these factors with pUL31 using Pearson’s
correlation coefficient (R2) as a statistic for quantifying colocalization. We determined
the average R2 value for pUL31 (YFP) and nucleolin to be 0.48  0.09 (Fig. 4). This
suggests that pUL31 and nucleolin exhibit a moderate degree of colocalization (43). In
contrast, the R2 value defined by UBF for pUL31 (YFP) and UBF is 0.34  0.10,
suggesting the absence of colocalization (Fig. 4). These data demonstrate that pUL31
is expressed within nucleolus-like domains by 72 hpi while being excluded from the
nuclear replication compartment. Within nucleolus-like domains, pUL31 overlaps
nucleolin but not the transcription factor UBF.
A UL31-deficient virus exhibits a replication defect at low multiplicities. To
study the impact of pUL31 on CMV replication, we generated UL31-deficient mutants
in the TB40/E strain of CMV using BAC recombineering. For one mutant, we replaced
the first approximately 1,200 bp of the UL31 gene with the bacterial galK gene and
designated the resulting virus the UL31del virus (Fig. 5A). This mutant is similar to that
constructed in CMV Towne UL31, which replicates poorly in fibroblasts (44). We also
generated the UL31in virus, where the galK sequence was introduced into the start
codon of UL31, replacing the start codon with galK while retaining the remaining UL31
sequence (Fig. 5A). These mutations were confirmed by sequence analysis and restric-
FIG 4 CMV pUL31 is excluded from the viral nuclear replication compartment and differentially localized to
nucleolar markers. Fibroblasts were infected using the UL31YFP virus, fixed and permeabilized at 72 hpi, and
stained using the indicated antibodies. Colocalization of proteins was calculated by defining a region of
interest determined by DAPI staining and determining the average Pearson correlation coefficient (R2)
between the indicated signals from 15 to 20 cells.
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tion enzyme digestion of the BAC DNA (data not shown). To investigate the impact of
pUL31 on viral replication, we infected fibroblasts with BAC-derived TBGFP, UL31del, or
UL31in at an MOI of 3 and measured viral release at 72 and 96 hpi. We quantified
significant growth defects for both the UL31del and UL31in mutant viruses compared to
the parental control (Fig. 5B). These data are consistent with observations made using
the CMV Towne strain (44) but not those made using the AD169 strain (42). A
FIG 5 Recombinant CMV mutant lacking expression of pUL31-YFP exhibits an MOI-dependent replication
defect. (A) UL31 was disrupted in CMV TB40/E (TBwt) by replacing 1,200 bp of the UL31 ORF with the galK
gene (UL31del) or insertion of galK into the first ATG of UL31 (UL31in). The locations of the first two ATG
sequences are indicated. (B) MRC-5 fibroblasts were infected using TBGFP, UL31del, or UL31in virus at an MOI
of 3. Viral titers from culture supernatants at 72 and 96 hpi were quantified using a TCID50 assay. Data are
from three biological replicates and two technical replicates, with error bars representing standard
deviations from the means. (C) Whole-cell lysates were collected at 96 hpi and analyzed using Western
blotting and the indicated antibodies. (D) A stop codon, TAG, was introduced into the second ATG of AD169
UL31YFP, resulting in UL31stop virus. (E) Fibroblasts were infected with UL31YFP or UL31stop virus at an MOI
of 3. Total RNA was collected at 96 hpi and analyzed using qRT-PCR with primers to UL32 (pp150) and
GAPDH. Data include three biological replicates and two technical replicates, with error bars representing
standard deviations from the means. Whole-cell lysates were analyzed by Western blotting. (F) Fibroblasts
were infected with UL31YFP or UL31stop virus at an MOI of 0.05 IU per cell. Whole-cell DNA was isolated at
the indicated times, and relative viral genomes were determined by qPCR using primers for UL123 and
GAPDH. Viral titers were determined from cell-free virus at 120 hpi. (G) Titers were also determined
following infection at an MOI of 3. Data include three biological replicates and two technical replicates, with
error bars representing standard deviations from the means.
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transposon insertion in UL31 of AD169 exhibited wild-type-like plaque sizes, which
prompted the authors to define UL31 as a nonessential gene (42). To investigate these
differences, we evaluated expression of the neighboring essential UL32 gene product
pp150 and a second late gene product, pp28, by Western blotting (31, 42). Infection
with either UL31del or UL31in resulted in a decrease in pp150 expression compared to
that of TBGFP, with a larger decrease seen during UL31del infection (Fig. 5C). Expression
of the late viral protein pp28 remained unchanged. These data suggest that the defects
in viral replication for UL31del and UL31in are the result of having disrupted pp150
expression, which may explain the differences between previous studies (42, 44). As an
aside, our observations confirm the importance of the UL31 region to the expression of
the neighboring UL32 gene.
To avoid disrupting pp150 expression, we constructed a third mutant virus,
UL31stop, by introducing a TAG amber stop codon into the UL31 ORF (Fig. 5D). Since no
antibody exists for UL31, the mutant was generated in the background of the UL31YFP
virus so we could monitor the loss of YFP expression. To confirm the loss of
pUL31-YFP, we infected fibroblasts with BAC-derived UL31YFP or UL31stop viruses at
an MOI of 3 (Fig. 5E). Cell lysates were collected at 96 hpi and processed for
quantitative reverse transcription-PCR (qRT-PCR) and Western blot analyses. We
observed equivalent levels of UL32 RNA and protein expression between viruses
(Fig. 5E). However, we failed to detect YFP expression during infection using the
UL31stop virus, indicating that pUL31 is no longer expressed (Fig. 5E). We next
evaluated the impact of pUL31 on viral replication. We infected fibroblasts using
UL31YFP or UL31stop virus at an MOI of 0.05 or 3 IU/cell and then quantified changes
in replication. At 120 hpi under low-MOI conditions, we quantified a 6-fold decrease
in UL31stop viral genomes and an accompanying drop in the viral titers compared
to the parental virus (Fig. 5F). Under high-MOI conditions, UL31stop virus replicated
similarly to UL31YFP virus (Fig. 5G). Together, our data indicate that a UL31-deficient
virus, exhibiting wild-type levels of pp150 expression, has a minor multiplicity-
dependent replication defect in cultured cells.
Alteration of pre-rRNA levels occurs during pUL31-deficient CMV infection. One
well-defined function of the nucleoli is ribosomal biogenesis (26). rRNA is transcribed by
RNA polymerase I and involves the transcription factor UBF as a 45S pre-rRNA contain-
ing internal and external transcribed spacers (ITS/ETS). This 45S pre-rRNA is processed
into 28S, 18S, and 5.8S fragments while removing ITS/ETS. To determine whether CMV
alters nucleoli and transcription of rDNA into pre-rRNA, we infected fibroblasts at an
MOI of 3 and evaluated changes in nucleolar morphology and pre-rRNA levels. As early
as 6 hpi, we detected changes in nucleolar organization by immunofluorescence
analysis using antibodies to UBF and nucleolin (Fig. 6A). CMV infection resulted in
relocalization of UBF from within nucleolar-like domains to diffuse nuclear staining.
Further, the size of domains containing nucleolin was increased in infected cells (Fig.
6A). To measure changes in transcription of rDNA, we quantified pre-rRNA levels using
quantitative RT-PCR and primers for the 5= ETS region. We detected an average 2.8-fold
transient increase in pre-rRNA at 6 hpi during UL31YFP virus infection compared to
levels for uninfected cells (Fig. 6B). A similar change was detected during infection
using TB40GFP virus (data not shown). Late during UL31YFP virus infection, we again
observed increasing levels of pre-rRNA compared to those for mock infection (Fig. 6B).
We completed these studies in parallel using the UL31-deficient UL31stop virus. Sur-
prisingly, starting at 48 hpi, we found a significant increase in pre-rRNA levels during
infection with UL31stop compared to the parental UL31YFP virus (Fig. 6B). The steady-
state levels of processed 18 and 28S rRNAs remained unchanged between the UL31stop
and UL31YFP infections (data not shown), suggesting that the observed change in ETS1
levels was not due to altered pre-rRNA processing. These data demonstrate that
infection in the absence of pUL31 results in significantly elevated levels of host cell
pre-rRNA.
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Changes in the colocalization of nucleolin with UBF have been associated with
altered pre-rRNA expression (45). To test whether pUL31 expression alters nucleolin-
UBF colocalization, we mock treated or infected fibroblasts using ADWT or UL31stop
virus and evaluated localization of these nucleolar proteins at 96 hpi. We determined
the R2 value for colocalization of UBF and nucleolin. Upon ADWT infection, we observed
a decrease in colocalization between nucleolin and UBF (R2  0.49) compared to both
mock-treated and UL31stop-infected cells (R2  0.88 and 0.82, respectively) (Fig. 6C).
FIG 6 CMV pUL31 alters nucleolar organization and function during infection. (A) MRC-5 fibroblasts were mock
treated or infected at an MOI of 3, fixed at 6 hpi, and stained using antibodies to UBF (red; left) or nucleolin (red;
right) and DAPI (blue). Data represent the average change in area of nucleoli relative to nucleus from mock-infected
(m) or infected cells at 6 hpi. Nucleolin and DAPI staining were used to define perimeters of nucleoli and the
nucleus, respectively. The relative area of nucleolus to nucleus per cell (in pixels) was determined and averaged
from 50 cells. (B) Fibroblasts were infected with UL31YFP or UL31stop virus or mock infected at an MOI of 3, and total
RNA was isolated at the indicated times. Mock-infected samples were collected at 96 h. Pre-rRNA levels were
determined using qRT-PCR and primers against the 5= external transcribed spacer (ETS) of rRNA relative to GAPDH.
Data are from three biological and two technical replicates, with error bars representing standard deviations from
the means. (C) Fibroblasts were mock treated or infected with the parental UL31YFP or UL31stop virus at an MOI of
3. At 96 hpi, samples were fixed and stained with antibodies to nucleolin or UBF. Colocalization was calculated by
defining a region of interest determined by nucleolin staining from 15 to 20 cells, and the average Pearson
correlation coefficient (R2) between the indicated signals was determined.
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These data suggest that pUL31-mediated changes in nuclear and/or nucleolar organi-
zation contribute to regulating pre-rRNA levels. However, future studies are required to
define the underlying relationship.
pUL31 interacts with CMV pUL76 with coexpression altering localization. Sev-
eral CMV proteins have been observed to localize to nucleolar-like domains or intranu-
clear aggregates, including pUL83, pUL27, pUL29, and pUL76 (13, 46–48). Preliminary
studies to identify pUL31 binding partners using mass spectrometry detected peptides
to pUL76 (data not shown). CMV pUL76 has been shown to associate with intranuclear
aggregates and to alter gene expression involving DNA damage machinery (46, 49–52).
Therefore, we investigated the possible association between pUL31 and pUL76. For
these studies, we constructed a pUL31 expression vector containing an amino-terminal
hemagglutinin (HA) epitope tag. Transfection of the plasmid into U373 resulted in
expression of a single protein at the predicted size of pUL31, i.e., 74 kDa (Fig. 7A). To
investigate interactions, we transfected U373 cells with pUL31-HA, pUL76-GFP, or
empty vector control and performed an immunoprecipitation (IP) experiment using an
anti-HA antibody to isolate pUL31-HA (Fig. 7B). As a control, we used CMV pUL29-HA,
which also localizes to nucleolus-like domains (46). Protein interactions were analyzed
by Western blotting using the indicated antibodies (Fig. 7B). The HA antibody efficiently
immunoprecipitated both pUL31-HA and pUL29-HA (Fig. 7B); however, only pUL76-GFP
was observed to interact with pUL31 (Fig. 7B). The reciprocal experiment gave the same
result; pUL31-HA was found in pUL76-GFP isolated complexes, verifying the interaction
(Fig. 7B). We next evaluated this interaction during infection. We transfected U373 cells
with pUL76-HA or empty vector control and then infected the cells with ADGFP or
UL31YFP virus (Fig. 7C). At 72 hpi, we immunoprecipitated UL31YFP and checked for the
presence of pUL76-HA by Western blotting. We observed an interaction between
pUL31-YFP and pUL76-HA using the UL31YFP virus but not ADGFP virus (Fig. 7C). These
data demonstrate that pUL31 interacts with pUL76 in both the presence and absence
of CMV infection.
We observed that pUL31 localizes to nucleolin-containing domains during infection,
and other laboratories observed pUL76 within intranuclear aggregates. To determine if
pUL31 and pUL76 colocalize in nucleoli, we analyzed the localization of pUL31 and
pUL76 in transfected cells. We transfected U373 cells with empty vector, pUL31-HA,
pUL76-GFP, or pUL31-HA and pUL76-GFP together. At 18 h posttransfection, cells were
fixed and analyzed by immunofluorescence using an anti-HA antibody and GFP fluo-
rescence. When expressed separately, pUL31-HA and pUL76-GFP localized to sub-
nuclear domains (Fig. 7D). Upon coexpression, we observed a strong degree of colo-
calization between pUL31-HA and pUL76-GFP with an average R2 value of 0.59  0.11
(Fig. 7D). In addition, expression of pUL76-GFP resulted in altered pUL31 localization
compared pUL31 alone (Fig. 7D). We observed pUL31 alone localized to pleomorphic
domains as circular, amorphic, and speckled subnuclear domains (Fig. 7E). However, in
cells expressing both pUL31 and pUL76, we detected increased circular subnuclear
domains containing pUL31-HA and a corresponding decrease in amorphic and speck-
led structures (Fig. 7E). These data demonstrate that pUL31 localizes to subnuclear
domains and that pUL76 alters the localization of pUL31 to distinct subnuclear do-
mains. Further, the data suggest that pUL76, like pUL31, associates with host cell
nucleoli.
Expression of pUL31 and pUL76 is sufficient to suppress pre-rRNA levels. We
were interested in determining whether pUL31 could influence pre-rRNA levels in the
absence of infection. For these studies, we again transfected U373 cells with empty
control or the pUL31-HA expression vector. We included expression vectors for pUL29
and pUL76 as well as a pUL31 carboxy-terminal truncation mutant in order to evaluate
any contributions of the conserved dUTPase-like motif (Fig. 8A). Following transfection,
each protein localized to nucleolar-like subnuclear structures (Fig. 8B). We determined
changes in pre-rRNA levels at 18 h posttransfection using qRT-PCR and primers for the
5= ETS. We observed an average decrease of 48% in pre-rRNA levels upon pUL31
CMV pUL31 Regulates Nucleolar Biology Journal of Virology
September 2017 Volume 91 Issue 18 e00593-17 jvi.asm.org 11
expression (Fig. 8C). Expression of pUL76 resulted in a 61% decrease in pre-rRNA levels,
while no changes were observed for pUL29 or pUL31234 (Fig. 8C). Coexpression of
pUL31 with pUL76 resulted in a 41% reduction, similar to the decrease observed with
pUL31 alone (Fig. 8C). These data demonstrate that pUL31 or pUL76 expression is
sufficient to reduce pre-rRNA levels, and that the pUL31 dUTPase-like motif contributes
to this activity.
We next asked whether transient pUL31 expression could repress pre-rRNA levels
during infection with UL31stop virus. To address the question, we transfected U373
cells with empty control, full-length pUL31, or truncated pUL31234 expression
vectors (Fig. 8A). After 18 h, transfected cells were infected with either UL31YFP or
FIG 7 CMV pUL31 specifically associates with pUL76, altering pUL31 localization. (A) U373 cells were transfected with
pUL31-HA or vector control. At 18 h posttransfection, proteins from whole-cell lysates were analyzed using Western
blotting and an anti-HA antibody. (B) U373 cells were transfected with pUL31-HA, pUL76-GFP, or pUL29-HA as a control.
At 18 h posttransfection, proteins from whole-cell lysates were immunoprecipitated using anti-HA or anti-GFP antibody
and analyzed using Western blotting and antibodies to the indicated epitopes. (C) U373 cells were transfected with
pUL76-HA or empty vector control. At 18 h posttransfection, cells were infected with UL31YFP or ADGFP virus at an MOI of
3. Whole-cell lysates were collected at 72 hpi. Proteins were immunoprecipitated with an anti-GFP antibody and analyzed
using Western blotting. (D) U373 cells were transfected with pUL31-HA, pUL76-GFP, or both pUL31-HA and pUL76-GFP.
Cells were fixed at 18 h posttransfection, stained using DAPI and an anti-HA antibody, and analyzed by confocal
microscopy. Colocalization was calculated by defining a region of interest determined by DAPI staining from 15 to 20 cells
and determining the average Pearson correlation coefficient (R2) between the indicated signals. (E) Multiple subnuclear
domains were observed (circular, speckled, or amorphic), counted in a blinded fashion, and presented as a percentage of
all domains observed using the indicated antibody.
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UL31stop virus, and pre-rRNA levels at 96 hpi were quantified using primers to the 5=
ETS (Fig. 8D). As presented earlier (Fig. 6B), we observed increased pre-RNA levels after
infection with the UL31stop virus compared to the level for UL31YFP (Fig. 8D). Similar
levels of pre-rRNA were found in UL31YFP-infected cells transfected with pUL31 or
a vector control (Fig. 8D), which indicates that pUL31 overexpression did not result in
further inhibition. In contrast, pUL31 expression in trans prevented the increase in
pre-rRNA levels seen during UL31stop infection (Fig. 8D). Expression of the carboxy-
terminal truncation pUL31234 partially reversed the increase in pre-rRNA. Overall, our
data demonstrate that pUL31 expression is sufficient to reduce pre-rRNA levels and
suggest that the dUTPase-like domain of pUL31 contributes to the activity.
DISCUSSION
During CMV replication, profound changes occur to the host cell nucleus, including
increased size, an altered proteome, and reorganized nuclear domains (9, 10, 53, 54).
Our recent studies investigating the nuclear proteome identified numerous viral pro-
teins associated with the nucleus at the onset of viral DNA synthesis (10). This included
multiple peptides matching to the predicted ORF of UL31, which contains a conserved
dUTPase-like motif (Fig. 1A and Table 1) (30). Here, we have investigated pUL31 and its
contribution to CMV replication. We have demonstrated that pUL31 is approximately 74
FIG 8 Expression of pUL31 is sufficient to reduce rRNA levels. (A) Domains identified within full-length
UL31, including nuclear localization sequence (NLS), arginine-rich motifs (RxnR) within an intrinsic
disorder region (IDR), and a conserved domain in betaherpesviruses (DUF570) containing a predicted
dUTPase. The truncated UL31224 contains only NLS, RxnR, and IDR motifs. (B) U373 cells were transfected
with pUL31-HA, pUL29-HA, pUL76-HA, or pUL31234-HA expression vectors. Cells were fixed and perme-
abilized at 18 h posttransfection and evaluated with immunofluorescence analysis using an anti-HA
antibody. (C) U373 cells were transfected with the indicated vectors, including an empty control (v).
Pre-rRNA levels relative to those of GAPDH were determined from total RNA isolated at 18 h posttrans-
fection using qRT-PCR. Data are from three biological and two technical replicates, with error bars
representing standard deviations from the means. (D) U373 cells were transfected with empty vector or
with pUL31-HA or pUL31234-HA expression vector, and at 18 h posttransfection they were infected using
UL31YFP or UL31stop virus at an MOI of 3. Total RNA was isolated at 96 hpi, and pre-rRNA levels were
determined using qRT-PCR and primers against the 5= external transcribed spacer (ETS) relative to
GAPDH. Data are from three biological and two technical replicates, with error bars representing
standard deviations from the means.
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kDa in size (Fig. 1E and 7A), with expression kinetics of a true late gene and member
of the Tp5 class of proteins (Fig. 2B) (6, 8). Intriguingly, around the onset of expression,
we detected perinuclear localization at 48 hpi, followed by accumulation within the
nucleus and eventual accumulation within nucleolar-like subdomains by 72 hpi (Fig. 2C
and 3B). Several viral proteins have been observed to associate with nucleoli, including
pUL76 (46), and we demonstrate that pUL31 interacts with pUL76 in the presence (Fig.
7C) and absence of infection (Fig. 7B). Expression of pUL31 and pUL76 altered nuclear
subdomain organization (Fig. 7D) and disrupted pre-rRNA expression levels (Fig. 8C).
However, unlike pUL76, disruption of pUL31 resulted in a minor disruption to CMV
replication in cultured cells (Fig. 5F).
Consistent with pUL31 localization, we detected a bipartite nuclear localization
motif at the amino terminus (Fig. 1A and Table 1). Proteins containing this signal use
the classical nuclear import machinery, importin-/, and we have previously demon-
strated that CMV induces expression of a subset of importin- adaptor proteins starting
at 24 hpi to support replication (10). Current annotation of the UL31 ORF in published
genomes identifies a downstream methionine as its starting codon, which lacks the NLS
motif. Our studies indicate that expression during infection (Fig. 1E) as well as upon
transfection of an expression vector (Fig. 7A) involves a methionine located 76 amino
acids upstream and includes the predicted NLS. Use of the upstream start is also
supported by ribosomal profiling studies done during CMV replication (3). As infection
progresses, pUL31 eventually accumulates in domains overlapping the nucleolar pro-
tein, nucleolin (Fig. 3 and 4). In contrast, pUL31 is excluded from the nuclear replication
compartment, defined by the pUL44 DNA processivity factor and pUL86 major capsid
protein (Fig. 4). Nucleolin is a common marker for nucleoli, which are fluid membrane-
less organelles within the nucleus. Further sequence analysis of pUL31 identified
arginine motifs (R-motifs) within an intrinsically disordered region (IDR) (Fig. 1A and
Table 1). This combination of features is commonly found in proteins localizing to
nucleoli, including nucleolin (27). We observed that expression of a carboxy-terminal
truncated version of pUL31 retaining these amino-terminal features remained associ-
ated with nucleoli (Fig. 8B). However, we were unable to express truncation mutants
lacking the amino terminus (data not shown). Recent biochemical studies indicate that
proteins containing similar R-motifs within IDRs can participate in liquid-liquid phase
separation, which is hypothesized to regulate the dynamic nature and protein compo-
sition of nucleoli (27, 28). Our data demonstrate that pUL31 localizes to nucleolar-like
domains late during infection, possessing motifs similar to those found in nucleolar
proteins and possibly involved in nucleolus-associated phase separation.
Nucleoli function in ribosome biogenesis and act as a central regulator of cellular
stress responses (55). To begin investigating the role of pUL31 in CMV replication, we
constructed several UL31-deficient viruses. A previous study disrupting the UL31 ORF in
CMV Towne strain demonstrated a replication defect (44). We introduced similar
mutations which also resulted in replication defects (Fig. 5B). However, these changes
inhibited expression of the neighboring antisense gene, UL32, which encodes the
tegument protein, pp150 (Fig. 5C). Upon introducing a stop codon within the UL31 ORF
and confirming wild-type levels of pp150 expression, we observed reduced replication
kinetics of the UL31-deficient virus at a low MOI but not high MOI compared to the
parental UL31YFP virus (Fig. 5F and G). We also evaluated the impact of pUL31 on rDNA
transcription by quantifying pre-rRNA levels. As early as 6 hpi we found a transient
increase in pre-rRNA levels (Fig. 6B), which coincided with CMV-mediated relocalization
of the nucleolar proteins UBF and nucleolin (Fig. 6A). The levels increased again after
48 hpi, and this occurred using both AD169 (Fig. 6B) and TB40/E strains (data not
shown). Other laboratories have shown that nucleolin participates in the formation of
the CMV nuclear replication compartment after 24 hpi (22), and we postulate that this
change contributes to the observed fluctuations in rRNA expression levels. In the
absence of pUL31, however, we observed a significant increase in pre-rRNA above that
detected in cells infected using the parental virus (Fig. 6B). Conversely, expressing
pUL31 in the absence of infection decreased pre-rRNA levels (Fig. 8C) and suppressed
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the high levels observed using the UL31-deficient virus (Fig. 8D). These studies dem-
onstrate that pUL31 is necessary and sufficient to regulate and suppress high levels of
pre-rRNA expression. Determining the functional significance of regulating pre-rRNA to
CMV infection and pathogenesis will be the focus of future studies.
Changes in pre-rRNA expression and processing alter nucleolar protein composition,
resulting in p53-dependent and p53-independent nucleolar stress responses (reviewed
in reference 56). These changes ultimately activate mechanisms that can lead to cell
cycle arrest and apoptosis. The importance of regulating nucleolar stress responses is
highlighted by recent studies demonstrating that a compound capable of inducing a
nucleolar stress response can serve as a potent antiviral agent against CMV replication
(29). As a nucleolar protein, it is conceivable that pUL31 controls pre-rRNA levels to
protect from or regulate a cell stress response. We postulate that suppression of a
nuclear stress response at late times is important during persistent infections and/or a
slower replication cycle. pUL31 may regulate the response by altering UBF-nucleolin
localization. We observed that colocalization of nucleolin and UBF is reduced upon
infection compared to the level for mock-infected cells but not when infected using the
UL31-deficient virus (Fig. 6C). In Huntington’s disease, nucleolin is sequestered away
from UBF and Pol I, resulting in reduced rDNA transcription and induction of a nuclear
stress response (45). Similar to pUL31, several proteins that participate in nucleolar
stress responses possess R-motifs within intrinsic disordered regions of the protein (27).
Our studies suggest a role for the dUTPase-like structure in the observed activity of
pUL31. This dUTPase-like domain exists in proteins from most herpesviruses, including
CMV proteins pUL31, pUL72, pp65, pp71, and pUL84 (30). However, the CMV proteins
lack additional domains required for dUTPase activity. Recently, herpesvirus proteins
containing dUTPase-like features have been implicated as pathogen-associated molec-
ular pattern (PAMP) proteins functioning to modulate immune responses (37). In
contrast to regulating nucleolar stress responses, it is conceivable that pUL31 has an
immunomodulatory role. Both pp65 and pp71 regulate intrinsic immune responses
with pp65 binding the double-stranded DNA sensors and IFI16 restricting it to the
nucleus and nucleoli (57–64). Perhaps the movement of pUL31 from a juxtanuclear
location to nucleoli participates in a similar activity (Fig. 2C). Like pUL31, pp65-deficient
viruses exhibit a minor replication defect in culture (57, 65). Intriguingly, we observed
that a pUL31 mutant lacking the dUTPase-like domain still localized to nucleoli yet
failed to suppress rRNA levels (Fig. 8C). Future studies will explore the role of pUL31 as
an immune modulator and its relationship to nucleolar biology.
As noted earlier, several CMV proteins have been observed to associate with
nucleoli, including pUL29 and pUL76 (46). The absence of a substantial growth defect
for the UL31-deficient virus may be the result of redundant functions. For example, we
have previously shown that pUL29 and pUL29/28 suppress p53-mediated gene expres-
sion (15, 16). Any role of pUL31 in regulating p53-dependent stress responses may be
masked by pUL29/28 expression. We demonstrated that pUL76 interacts with pUL31 in
the presence and absence of infection (Fig. 7B and C). While not studied comprehen-
sively, we found that pUL76 expression decreases pre-rRNA levels similar to pUL31 in
the absence of infection (Fig. 8C). These data support the notion of a redundancy in
function between pUL31 and pUL76. The concept that CMV expresses a protein that
decreases pre-rRNA levels in a cell that requires increased protein production to
support the viral life cycle seems counterintuitive. An alternative role of pUL31 may be
to simply help reorganize membrane-less domains within the nucleus, and the changes
that we observed in pre-rRNA expression are an indirect consequence. We observed
that pUL31 does not colocalize with UBF, a crucial player in the initiation of RNA
polymerase 1-mediated transcription, but moderately colocalizes with nucleolin (Fig. 4).
In addition to binding pUL31, expression of pUL76 changed the localization of pUL31
(Fig. 7D). pUL76 expression induces double-strand breaks and aberrant spindle forma-
tion in uninfected cells (49–51). Proper spindle formation is important during mitosis
and regulated by nucleolar proteins. This further supports the notion that pUL76, along
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with pUL31, participates in reorganizing domains within the nucleus to support infec-
tion.
Our studies demonstrate that CMV pUL31 associates with cellular nucleolar-like
domains late during infection and regulates aspects of nucleolar biology. The contri-
bution of these changes to replication remains unclear. However, nucleoli are impor-
tant regulators of cellular stress responses capable of inducing cell cycle arrest and/or
apoptosis, and they are proposed targets for cancer therapies (66). It is our goal to
understand how CMV proteins, including pUL31, regulate nuclear and nucleolar biology
as a means to uncover unique therapeutic strategies to stimulate the cell’s intrinsic
ability to suppress infection.
MATERIALS AND METHODS
Biological reagents. MRC-5 fibroblasts (ATCC) and U373 cells were propagated in Dulbecco’s
modified Eagle medium (DMEM) (ThermoFisher Scientific) containing 7% fetal bovine serum (FBS)
(Atlanta Biologicals) and 1% penicillin-streptomycin (ThermoFisher Scientific). Cells were grown to
approximately 70% confluence and serum starved using 0.5% FBS for 24 h to synchronize the population
prior to infections and transfections unless otherwise noted.
The CMV strain AD169 (ADWT), AD169 encoding GFP (ADGFP), and strain TB40/E encoding GFP (TBGFP)
were produced from the bacterial artificial chromosome (BAC) clones (67–69). The AD169 UL31YFP BAC
clone (referred to as UL31YFP) was constructed by introducing the YFP gene at the 3= end of UL31
using recombineering methods previously described for other CMV genes and primers specific to
UL31 (5=-TGGGCGACATGCAATTGCCCGCGGACAACTTTCTCACGTCTCCCCATCCCCCGGAAGAAGATGGA
AAAAG-3= and 5=-AATGAAACCATCGGATAGTGACGTGTCGGGAAAGGAGGACGGACGGAGGGGTCGTGGAA
TGCCTTCG-3=, with CMV sequence underlined) (Integrated DNA Technologies) (57). For UL31stop BAC
(UL31stop), a stop codon, TGA, was introduced into the second predicted start codon, ATG, using the
UL31YFP BAC. This was done in order to monitor the loss of pUL31 protein expression by YFP. To
construct the BAC clone, the galK gene was amplified by PCR using primers flanking the second ATG
codon of UL31 (5=-GGCGACGACACGGCGACGGTCAACAGGGTCACAAGCGTGGGTTTGTCCCCTCAGCACTGT
CCTGCTCCTT-3= and 5=-CGCCGGAGGAAACGGGGACCGGCAACGACGGCGGTGGCGGCGACCAGATTCCTGTT
GACAATTAATCATCGGCA-3=, with CMV sequence underlined). The resulting PCR product was electropo-
rated into Escherichia coli SW105 cells containing AD169 UL31YFP BAC clone and grown under
chloramphenicol and galactose selection (70). The galK gene was replaced by introducing a double-
stranded oligonucleotide containing UL31 sequence with an amber mutation, TAG (5=-CCGGAGGAAAC
GGGGACCGGCAACGACGGCGGTGGCGGCGACCAGATTTAGTGGGGACAAACCCACGCTTGTGACCCTGTTGA
CCGTCGCCGTGTCGTCG-3=, with the nucleotide substitution underlined) and chloramphenicol and
2-deoxygalactose counterselection. Additional UL31 mutations were constructed using the TB40/E BAC
by replacing the majority of the UL31 gene (UL31del) or disrupting the gene (UL31in) with the insertion
of galK using sequence-specific primers (upstream primer 5=-AGTCGGCTACATGCGCCCTGGGTCTGACGC
TCCAAAGCGTACGCAGTCTGTCAGCACTGTCCTGCTCCTT-3= with UL31in, 5=-CCGGGCCCCGCGTTCAAGACG
GCGTGCCGTGACGCTCGATGGGTCCGCTTCCTGTTGACAATTAATCATCGGCA-3=, or with UL31del, 5=-GCCTC
GTCGTCGTCCATCGTGCCGCGGAACTGCGCGAGGTAGCGCGTAATCCTGTTGACAATTAATCATCGGCA-3=;
CMV sequences are underlined). All clones were confirmed by sequencing across the junctions of
specific changes and evaluated by restriction enzyme digestion compared to the parental BAC clone.
Viral stocks were prepared by transfecting BAC DNA into MRC-5 fibroblasts with a UL82 expression
vector (71) using electroporation at 260 mV for 23 ms with 4-mm-gap cuvettes and a Gene Pulser
Xcell electroporation system (Bio-Rad Laboratories). Culture medium was then collected and pel-
leted through a sorbitol cushion (20% sorbitol, 50 mM Tris-HCl, pH 7.2, 1 mM MgCl2) at 55,000  g
for 1 h in a Sorvall WX-90 ultracentrifuge and SureSpin 630 rotor (ThermoFisher Scientific) (72). Titers
of viral stocks were determined using a limiting dilution assay (50% tissue culture infectious dose
[TCID50]) and MRC-5 cells in 96-well dishes. We determined CMV IE1-positive cells at 2 weeks
postinfection and refer to the resulting titers as infectious units (IU) per milliliter.
Infections were completed using a multiplicity of infection (MOI) of 3 IU/cell, unless otherwise noted,
with the number of cells counted using a hemocytometer prior to infection. After 2 hpi, cells were
washed with phosphate-buffered saline (PBS) and new medium was added. In drug treatment experi-
ments, compounds were added at 0 hpi and replaced every 24 h. Cells were treated with 10 M
ganciclovir (GCV; Sigma-Aldrich) or dimethyl sulfoxide (DMSO) as a vehicle control.
Plasmids were transfected using Fugene 6 reagent (Promega Corporation) by following the manu-
facturer’s protocol. The pCGN-pUL29 and pCGN-pp71 plasmids have been previously described (71, 73).
The nucleolin-mCherry plasmid was generously provided by Keiichi Nakayama (Kyushu University) (74),
the pUL76-GFP plasmid was generously provided by Shang-Kwei Wang (Kaohsiung Medical University)
(48), and the pUL76-HA vector was generously provided by Robert Parkhouse (Instituto Gulbenkian de
Ciência) (75). The pUL31 expression plasmid, pcDNA-pUL31HA, was constructed using the pcDNA3
vector. The UL31 gene was amplified by PCR using Platinum Taq DNA polymerase high fidelity
(ThermoFisher Scientific) and an upstream primer encoding the HA epitope sequence (5=-TCCTCGAGG
CCACCATGTACCCATACGATGTTCCAGATTACGCTAAGCGGACCCATCGAGCGTC-3=, with HA sequence un-
derlined) and a downstream primer (5=-ATATCTAGATCAGGGATGGGGAGACGTGAG-3=) containing XhoI
and XbaI restriction enzyme sites. The resulting product was introduced into the equivalent sites in
pcDNA3. To construct the pUL31234-HA expression vector, we PCR amplified the first third of UL31 using
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the template pcDNA-pUL31HA and an upstream primer (5=-TCACGGCACGCCGTCTTGAACGCAGGGCCC-
3=) with a downstream primer containing a stop codon and sequences to pcDNA3 (5=-CTCTAGCATTTA
GGTGACACTATAGAATAGGGCCCTCAGGCCGTCAGGTGCGAGGC-3=, with UL31 sequence underlined). The
product was inserted into pcDNA-pUL31HA using the restriction enzyme ApaI. Expression plasmids were
verified using sequence analysis of the inserted gene.
The following antibodies were used in these studies for Western blot (WB), immunoprecipitation (IP),
or immunofluorescence (IF) analysis with the amount of antibody or dilution used indicated: mouse
anti-GAPDH (clone 0411; WB, 1:10,000; Santa Cruz Biotechnology), mouse anti-HA (clone HA-7; WB,
1:1,000; IP, 5 g; Sigma-Aldrich), mouse anti-GFP (WB, 1:1,000; IP, 5 g; IF, 1:100; Santa Cruz Biotech-
nology), mouse anti-UBF (clone F-9; IF, 1:100; Santa Cruz Biotechnology), mouse anti-nucleolin (clone
C-23; IF, 1:100; Santa Cruz Biotechnology), preconjugated anti-nucleolin Alex Fluor 488 (IF, 1:100; Abcam),
and mouse anti-pUL44 (clone 10D8; WB, 1:1,000; IF, 1:100; Virusys). The CMV antibodies mouse anti-
pUL123 (clone 1B12; WB, 1:1,000; IF, 1:100) and mouse anti-pp28 (clone 10B4; WB, 1:1,000) were
generously provided by Tom Shenk (Princeton University) (76, 77). Mouse anti-MCP/UL86 (clone MAb
28-4; IF, 1:5) and mouse anti-pp150 (clone MAb 36-14; WB, 1:500) were generously provided by William
Britt (University of Alabama, Birmingham) (78). Goat anti-mouse immunoglobulin (IgG) conjugated with
horseradish peroxidase (HRP) secondary antibody was used for Western blot analysis at 1:10,000 (Jackson
ImmunoResearch). Donkey anti-mouse and anti-rabbit IgG conjugated with Alexa Fluor 488 and 568
secondary antibodies were used for IF analysis at 1:500 (Thermo Fisher Scientific).
Analysis of protein and nucleic acid. Steady-state protein levels were measured by Western
blotting. Cells were resuspended in lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5% NP-40) and
lysed by sonication. Protein samples then were resolved by sodium dodecyl sulfate–10% polyacrylamide
gel electrophoresis (SDS-PAGE) and transferred to a Protran nitrocellulose membrane (Sigma-Aldrich) by
semidry transfer using a Trans-Blot turbo transfer system (Bio-Rad). The membrane was blocked in 5%
milk in PBS-T (PBS, 0.05% Tween 20) for 1 h, incubated in primary antibody diluted in 5% milk in PBS-T
for 2 h at room temperature or 4°C overnight, and then incubated in secondary antibody conjugated to
HRP in 5% milk for 1 h at room temperature. HRP-conjugated antibodies were detected using enhanced
chemiluminescence reagents (ECL) (GE Healthcare) and film. For immunoprecipitation experiments, cells
were resuspended in lysis buffer containing cOmplete protease inhibitor cocktail (Roche) and lysed by
sonication. Cell lysates were precleared for 30 min at 4°C with Protein G Dynabeads (ThermoFisher
Scientific). Protein G Dynabeads were washed in lysis buffer, bound to the antibody for 30 min at room
temperature, washed again, and incubated with precleared lysates for 3 h at 4°C with rotation.
Protein-bound beads were washed five times in lysis buffer, resuspended in Laemmli sample buffer, and
analyzed using Western blotting as described above.
Cellular and viral DNA and RNA contents were determined using quantitative PCR (qPCR) analysis.
Cells were collected, resuspended in lysis buffer (400 mM NaCl, 10 mM Tris, pH 8.0, 10 mM EDTA, 0.1
mg/ml proteinase K, 0.2% SDS), and incubated at 37°C overnight. DNA was extracted using phenol-
chloroform and precipitated using ethanol. qPCR was completed using primers for CMV UL123 (5=-
GCCTTCCCTAAGACCACCAAT-3= and 5=-ATTTTCTGGGCATAAGCCATAATC-3=) and cellular GAPDH (5=-
ACCCACTCCTCCACCTTTGAC-3= and 5=-CTGTTGCTGTAGCCAAATTCCGT-3=). Quantification was performed
using FastStart Universal SYBR green master mix (Roche) and the QuantStudio 6 Flex real-time PCR
system (ThermoFisher Scientific). Relative quantities of DNA were determined using an arbitrary standard
curve within each experiment for each primer set and normalized to GAPDH levels. For studies involving
RNA, we isolated total RNA from cells using TRIzol reagent (ThermoFisher Scientific) by following the
manufacturer’s instructions. Approximately 2 g of RNA was treated with DNA-free DNA removal kit
(ThermoFisher Scientific) and used to synthesize cDNA with random hexamers and Superscript III reverse
transcriptase (ThermoFisher Scientific). Studies on UL31 expression required cDNA synthesis using a
gene-specific primer, 5=-TGCCGCATGGTTTCCTCG-3=. qPCR was performed as described above using
primers against UL31 (5=-TGTCCATCACCGAGCAGTACAACA-3= and 5=-TGGTGGAGCAGAGCAGAAAGA
AGA-3=), UL32 (5=-CATCTTTACGCCCATCAAGAAAC-3= and 5=-TCTGACTGCCCGAGGATAA-3=), GAPDH (5=-
ACCCACTCCTCCACCTTTGAC-3= and 5=CTGTTGCTGTAGCCAAATTCCGT-3=), and pre-rRNA external tran-
scribed spacer 1 (5=-GAACGGTGGTGTGTCGTTC-3= and 5=-GCGTCTCGTCTCGTCTCACT-3=). Relative quantities
of cDNA were determined using an arbitrary standard curve within each experiment for each primer set, and
viral cDNA was normalized to GAPDH cDNA.
Immunofluorescence studies. For immunofluorescence, cells were plated in 6-well dishes contain-
ing glass coverslips at approximately 60% confluence. After the indicated perturbation, cells were
analyzed by either live-cell microscopy using a Nikon Eclipse TS100 inverted microscope or fixed for
immunofluorescence analysis using 4% paraformaldehyde for 20 min at room temperature. Fixed cells
were permeabilized in 0.1% Triton X-100 for 30 min, blocked using 3% bovine serum albumin (BSA) in
PBS-T for 30 min, and then incubated using the indicated primary antibody diluted in 3% BSA in PBS-T
for 2 h at room temperature or overnight at 4°C. Samples were washed three times with PBS-T, incubated
using the appropriate Alexa-Fluor-conjugated secondary antibody for 1 h at room temperature, and
washed. Coverslips were placed on glass slides in Prolong Gold with DAPI antifade reagent (Thermo-
Fisher Scientific). Images were acquired at 60 oil magnification on a Nikon A1 spectral confocal
microscope (Nikon). Colocalization was determined by manually defining a region of interest (ROI) based
upon either DAPI or nucleolar staining, as indicated in the figure legends, and colocalization coefficients
were calculated using NIS Elements analysis software (Nikon).
Statistical analysis. The data are representative of 3 or more biological replicates. Reported values
are given as the means from all replicates  standard deviations. To calculate statistical significance, the
CMV pUL31 Regulates Nucleolar Biology Journal of Virology
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Student t test was used to compare two samples, and analysis of variance (ANOVA) was used when more
than two samples were being analyzed. An asterisk indicates a significant P value of less than 0.05.
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